LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
about
Infectious and coronary artery diseaseYear in review 2010: Critical Care--Multiple organ dysfunction and sepsisGenetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunctionFunctional analysis and molecular dynamics simulation of LOX-1 K167N polymorphism reveal alteration of receptor activity.Opuntia spp.: Characterization and Benefits in Chronic Diseases.Reverse cholesterol transport pathway in experimental chronic renal failure.Syncytiotrophoblast extracellular vesicles impair rat uterine vascular function via the lectin-like oxidized LDL receptor-1Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsiaGene therapy in the treatment of peripheral arterial disease.LOX-1 in atherosclerosis: biological functions and pharmacological modifiers.Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease.Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cellsSurfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeabilityScavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseUptake and accumulation of oxidized low-density lipoprotein during Mycobacterium tuberculosis infection in guinea pigs.DNA-binding small molecules as inhibitors of transcription factors.Scavenger receptor-A (CD204): a two-edged sword in health and diseaseInhibitory C-type lectin receptors in myeloid cells.Oxidized low density lipoprotein induces bone morphogenetic protein-2 in coronary artery endothelial cells via Toll-like receptors 2 and 4.Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligandWhole tumor antigen vaccines.Ox-LDL induces dysfunction of endothelial progenitor cells via activation of NF-κB.Protective effects of let-7a and let-7b on oxidized low-density lipoprotein induced endothelial cell injuriesInhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces leukocyte adhesion within the intestinal microcirculation in experimental endotoxemia in rats.Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell LinesHigh plasma levels of oxidatively modified low-density lipoproteins are associated with the suppressed expression of immunomodulatory molecules in patients with hematological malignancies.Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment.Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-κB/LOX-1 Pathway.Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors.Preliminary Analysis of Modified Low-Density Lipoproteins in the Serum of Healthy and Obese Dogs and Cats.C-type lectin-like receptors on myeloid cells.Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3AMechanisms for cellular cholesterol transport: defects and human disease.Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1Resveratrol Enhances Autophagic Flux and Promotes Ox-LDL Degradation in HUVECs via Upregulation of SIRT1Cardiovascular actions of the peroxisome proliferator-activated receptor-alpha (PPARalpha) agonist Wy14,643.Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.
P2860
Q26750409-37850D0A-8EBB-44E3-80B5-822951D867E9Q26823098-3237554D-B090-4EBB-8171-888B07C42D5BQ26824460-A3BB4D99-7AC4-4C96-80A7-62C801EBD0EDQ33413089-DA5B5DFD-083E-4D0F-93DC-03D37760E7CCQ33593007-F9281DF7-569C-4883-9B43-52F4170834BEQ33620325-18EA266B-B56E-4BAF-92AB-E3BEB60E945AQ33866050-7A3E9768-C6CC-40C4-AB88-84E1C49C6D7BQ33879138-F97F7AFB-974B-4CA9-B044-2FA3A72F1CCFQ33944749-F8197C27-C38F-4C73-BD9B-006A7E74A904Q34070287-F79EFEE1-5869-47C0-B349-0FC3040499C1Q34079451-55D08C8C-D390-4C15-AE77-EB139579F0E8Q34080703-3F8356CE-31B5-4A92-B024-C125CF6C39B5Q34110474-6179BFD3-71A0-4B32-A29B-7700BE566BACQ34197408-B59FACB2-F7B9-4F01-9EB6-279BE60DD517Q34218552-06BB42C5-B243-48AB-B1E3-67E036052153Q34228219-9A1B731A-2488-474A-AC82-696FB3FA6417Q34253203-2B5AE3B6-F3A6-40DB-9C4D-D6D7743A1F35Q34313964-B3157936-174E-4DF6-A8A0-B20C3E64926BQ34700805-C11C8DBA-23F4-4AEE-9573-A397A0BBC3AFQ34752149-0DD8B06B-499C-4994-AF80-9B8E1955AD72Q35011105-1F855ECE-3CFA-413C-88A0-8AA684A2A630Q35058235-C7D30058-BBB8-4F5B-8DDD-CCE193E5D93BQ35189234-A7C43CAD-3000-4C0B-A3E5-3A76A5B2056AQ35270619-A2979C09-63CF-4BB9-B99E-3AA711C9DA0DQ35561312-C5A68F9A-B221-487A-86D5-C8665962E94DQ35664761-22659986-5D5A-45CB-8378-5180B30EC4C6Q35758517-F8E314B4-F08B-4165-9FA2-C0A3D544ED4CQ35857659-40CACE82-F31A-46EF-8C79-8252510CD9F1Q35890327-A24452CA-8A3F-4A80-984D-1175D6403657Q35950665-7F2599BC-83DA-4876-9C9D-B27750696E35Q35952837-DAE8752E-5293-46D4-9FEE-0A406FA6B3CCQ36353238-C10C65AB-02C8-4752-BA66-C664067E6FAFQ36497532-EDF27242-0F1B-44B0-91F4-FC8DC2949311Q36528775-15F80796-774D-460E-A8AE-912EBC339DCCQ36610465-8B655314-38DD-429D-AC3E-A037549B21E7Q36615134-13EB7D12-15DF-425A-841E-7F9A21DDB60EQ36741982-8B64BFBE-9557-43B0-98BF-FBE9DE1013E2Q36872068-77167299-F130-477C-A668-3E442F58AF3DQ36872076-E31A18FA-EDDA-44D9-BACE-A59672FEC035Q36958112-0EAB82EC-8ED1-4189-A160-AC5DEF31FC02
P2860
LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@ast
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@en
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@nl
type
label
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@ast
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@en
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@nl
prefLabel
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@ast
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@en
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@nl
P2093
P921
P1476
LOX-1, the receptor for oxidiz ...... sfunction and atherosclerosis.
@en
P2093
Mingyi Chen
Tatsuya Sawamura
Tomoh Masaki
P304
P356
10.1016/S0163-7258(02)00236-X
P577
2002-07-01T00:00:00Z